Filing
Spy
Filing
Spy
Home
About
FNCH
Finch Therapeutics Group Inc
Clinical-stage biotechnology company developing microbiome therapies
CUSIP: 31773D101
Healthcare
US
1 holder
Ownership
Activity
2022 Q4
2 of 9 quarters
Total Value
$489.0K
Total Shares
1.02M
Net Share Change
-104.1K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Baupost Group LLC
$489.0K
1.02M
0.0%
TRIM
-104.1K
(-9.3%)
Baupost Group LLC
$489.0K
1.02M shares
TRIM
-104.1K
(-9.3%)
FNCH — Finch Therapeutics Group Inc - FilingSpy